RU97117526A - METHOD FOR NORMALIZING CELL EXCHANGE PROCESSES AND DRUG FOR THESE PURPOSES - Google Patents

METHOD FOR NORMALIZING CELL EXCHANGE PROCESSES AND DRUG FOR THESE PURPOSES

Info

Publication number
RU97117526A
RU97117526A RU97117526/14A RU97117526A RU97117526A RU 97117526 A RU97117526 A RU 97117526A RU 97117526/14 A RU97117526/14 A RU 97117526/14A RU 97117526 A RU97117526 A RU 97117526A RU 97117526 A RU97117526 A RU 97117526A
Authority
RU
Russia
Prior art keywords
drug
hydrolyzate
protein material
cell
purposes
Prior art date
Application number
RU97117526/14A
Other languages
Russian (ru)
Other versions
RU2120297C1 (en
Inventor
В.Г. Попов
А.Л. Попов
О.Л. Белов
С.А. Дмитриев
Е.Г. Сиротский
Original Assignee
Товарищество с ограниченной ответственностью "Дека-Н"
Filing date
Publication date
Application filed by Товарищество с ограниченной ответственностью "Дека-Н" filed Critical Товарищество с ограниченной ответственностью "Дека-Н"
Priority to RU97117526/14A priority Critical patent/RU2120297C1/en
Priority claimed from RU97117526/14A external-priority patent/RU2120297C1/en
Application granted granted Critical
Publication of RU2120297C1 publication Critical patent/RU2120297C1/en
Publication of RU97117526A publication Critical patent/RU97117526A/en

Links

Claims (6)

1. Способ нормализации обменных процессов в клетке путем воздействия на клетку лекарственным препаратом Олифеном, отличающийся тем, что одновременно на клетку воздействуют препаратом, включающим гидролизат белкового материала.1. A method of normalizing metabolic processes in the cell by exposing the cell to the drug Olifen, characterized in that the cell is simultaneously exposed to the drug, including the hydrolyzate of the protein material. 2. Способ по п.1, отличающийся тем, что в качестве препарата, включающего гидролизат белкового материала, используют пищевую добавку Иммуновит. 2. The method according to claim 1, characterized in that as a preparation comprising a hydrolyzate of protein material, a food supplement Immunovit is used. 3. Способ по п.1 или 2, отличающийся тем, что для воздействия на организм в него пероральным путем вводят Олифен из расчета 1-30 мг/кг массы тела и препарат, включающий гидролизат белкового материала в количестве 50-100 мг/кг массы тела (по сухому весу). 3. The method according to claim 1 or 2, characterized in that for exposure to the body, Olifen is administered orally in the amount of 1-30 mg / kg body weight and a preparation comprising a hydrolyzate of protein material in an amount of 50-100 mg / kg body (by dry weight). 4. Средство, нормализующее обменные процессы в клетке, содержащее лекарственный препарат Олифен, отличающееся тем, что дополнительно препарат, включающий гидролизат белкового материала. 4. A tool that normalizes metabolic processes in the cell, containing the drug Olifen, characterized in that it is additionally a drug including a hydrolyzate of protein material. 5. Средство по п.4, отличающееся тем, что в качестве препарата, включающего гидролизат белкового материала, содержит пищевую добавку Иммуновит. 5. The tool according to claim 4, characterized in that as a preparation comprising a hydrolyzate of protein material, contains a food supplement Immunovit. 6. Средство по п.4 или 5, отличающееся тем, что соотношение в нем активных компонентов таково, что на 100 мг Олифена приходится 5 - 10 г гидролизата (по сухому весу). 6. The tool according to claim 4 or 5, characterized in that the ratio of active components in it is such that 5 to 10 g of hydrolyzate (100% dry weight) falls per 100 mg of Oliphene.
RU97117526/14A 1997-10-31 1997-10-31 Method of normalization of metabolic processes in cell and a preparation for these aims RU2120297C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU97117526/14A RU2120297C1 (en) 1997-10-31 1997-10-31 Method of normalization of metabolic processes in cell and a preparation for these aims

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU97117526/14A RU2120297C1 (en) 1997-10-31 1997-10-31 Method of normalization of metabolic processes in cell and a preparation for these aims

Publications (2)

Publication Number Publication Date
RU2120297C1 RU2120297C1 (en) 1998-10-20
RU97117526A true RU97117526A (en) 1999-01-27

Family

ID=20198312

Family Applications (1)

Application Number Title Priority Date Filing Date
RU97117526/14A RU2120297C1 (en) 1997-10-31 1997-10-31 Method of normalization of metabolic processes in cell and a preparation for these aims

Country Status (1)

Country Link
RU (1) RU2120297C1 (en)

Similar Documents

Publication Publication Date Title
CA1180277A (en) Solid medicament formulations containing nifedipine, and processes for their preparation
FR2634376B1 (en) NOVEL SOLID AND POROUS UNIT FORM COMPRISING MICROPARTICLES AND / OR NANOPARTICLES, AS WELL AS ITS PREPARATION
DE69006365D1 (en) UNCOATED PHARMACEUTICAL REACTION TABLET.
EP1435240A3 (en) Solid oral dosage form comprising a combination of methformin and glibenclamide
DK0481294T3 (en) Solid, fast-soluble drug preparation containing S- (carboxymethyl) -L-cysteine and / or N-acetylcysteine
KITAGAWA et al. Efficacy of monotherapy with benazepril, an angiotensin converting enzyme inhibitor, in dogs with naturally acquired chronic mitral insufficiency
SE8702941D0 (en) PHARMACEUTICAL, N-ACETYL-CYSTEIN-CONTAINING, WATER-SOLUBLE COMPOSITION
US6203820B1 (en) Compositions and methods for enhancing protein anabolism and detoxification
EP1637142A3 (en) Stable solid formulation of enalapril salt and process for preparation thereof
EP0344997A3 (en) Use of phytic acid or a salt thereof as an activator of hypoxic cells and a circulatory ameliorator
FR2682874B1 (en) PROCESS FOR THE PREPARATION OF AN EXTRACT OF ACTIVE PRINCIPLES IN THE DRY ADSORBABLE FORM AND ADSORBABLE MICROGRANULES THUS OBTAINED.
AU1300383A (en) Amides useful in the treatment of diabetes
RU97117526A (en) METHOD FOR NORMALIZING CELL EXCHANGE PROCESSES AND DRUG FOR THESE PURPOSES
PH19471A (en) Oxindole derivatives and pharmaceutical composition containing them
JPS5781409A (en) External plaster
DE68907268D1 (en) USE OF PHYTINIC ACID AS AN ANTIDOT AGAINST ALCOHOL POISONING.
JPS5962528A (en) Fatigue recoverying agent
MY101266A (en) Pharmaceutical formulations
JPS5661311A (en) Thial amide or prolonged pharmaceutical preparation comprising its salt
CA2384301A1 (en) Sustained-release drug formulations for implantation
SE8603517D0 (en) HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND PHARMACEUTICAL FORMULATION
RU98105049A (en) ANTISISCHEMIC AND ANTIATHEROSCLEROTIC MEDICINE
RU2014077C1 (en) Substance for integral correction of metabolic acidosis and alkalosis
KR100219439B1 (en) Young antler based capsule preparation
JP2688770B2 (en) Iron absorption promoter